Geode Capital Management’s Onconetix ONCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,185
Closed -$17.7K 4536
2026
Q1
$17.7K Buy
+1,185
New +$61.7K ﹤0.01% 4462
2025
Q2
Sell
-16
Closed -$5.27K 4500
2025
Q1
$5.27K Buy
16
+3
+23% +$5.15K ﹤0.01% 4456
2024
Q4
$34.9K Buy
+13
New +$132K ﹤0.01% 4300
2024
Q3
Sell
-1
Closed -$15.9K 4568
2024
Q2
$15.9K Buy
+1
New +$25.4K ﹤0.01% 4487
2024
Q1
Hold
0
4566
2023
Q4
Hold
0
4583
2023
Q3
Hold
0
4563
2023
Q2
Hold
0
4462
2023
Q1
Hold
0
4487
2022
Q4
Hold
0
4829
2022
Q2
Hold
0
-$215K 5030
2022
Q1
Hold
0
4342

Other funds holding ONCO

Geode Capital Management's ONCO Position: Q2 2026 in Review

Geode Capital Management sold out of Onconetix (ONCO) in Q2 2026, closing a stake of 1,185 shares — an estimated $17.7K sold.

Geode Capital Management first reported a position in ONCO in Q2 2024 and held it in 4 quarters. The position peaked at $34.9K in Q4 2024. 6 funds tracked by Wall St. Rank hold ONCO as of Q2 2026.

  • Geode Capital Management reported no remaining Onconetix position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 1,185 Onconetix shares in Q2 2026, an estimated $17.7K.
  • Geode Capital Management first reported a position in Onconetix in Q2 2024 and held it in 4 quarters.
  • Geode Capital Management's Onconetix position peaked at $34.9K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Onconetix as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.